Renagel Tablets Sevelamer Hydrochloride 800 MG Tablets Trademark Details

Renagel Tablets Sevelamer Hydrochloride 800 Mg Tablets was registered on Tuesday, May 1, 2007 and is currently owned by Genzyme Corporation under the registration number 3237977 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 10 years ago on Friday, December 6, 2013, according to the United State Patent & Trademark Office
Word Mark Renagel Tablets Sevelamer Hydrochloride 800 Mg Tablets
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Genzyme Corporation of Cambridge, MA

View all trademarks for Genzyme Corporation
Other Trademarks for Genzyme Corporation
Serial Number 78445105
Registration Number 3237977
Status Date Friday, December 6, 2013
Filing Date Friday, December 6, 2013
Registration Date Tuesday, May 1, 2007
Attorney Richard D. Allison

Correspondent

Richard D. Allison
GENZYME CORPORATION
Legal Department
15 Pleasant Street Connector
FRAMINGHAM, MA 01701

Case File Statements

Disclaimer with Predetermined Text "Tablets Sevelamer Hydrochloride 800 Mg Tablets"
Description of Mark The mark consists of whirlwind like design.
Goods & Services Pharmaceutical preparations for the treatment of Renal Disease; phosphate binders for treatment of hyperphosphatemia
Pseudo Mark Renagel Tablets Sevelamer Hydrochloride 800 Milligram Tablets

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, December 6, 2013
First Use Anywhere Monday, October 4, 2004
First Use In Commerce Monday, October 4, 2004
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.